Targeting leukemia stem cells in combination with standard chemotherapy may improve treatment for chronic myeloid leukemia.

Elliott Sohn, MD, will take a break from being an ophthalmologist this week to help raise awareness of vision research in a unique way

University of Iowa spin-off Viewpoint Molecular Targeting has recently been awarded a $2 million Phase II NIH SBIR to support development of a new treatment for metastatic melanoma.

Allyn Mark, MD, has received what is widely considered the premier award in hypertension research

Peter Densen, MD, was honored with the 2017 Ron Arky Award from the Learning Communities Institute

The National Cancer Institute is giving $12.4 million for lymphoma research

Rare mutations cluster in specific biological pathways, suggest new targets for ED treatment